Search

Issue
Title
Authors
Predictors of class IC antiarrhythmic drugs efficacy in patients with paroxysmal form of atrial fibrillation
Khalikova M.A., Tsaregorodtsev D.A., Beraya M.M., Sedov A.V.
Pentraxin-3 – a promising biological marker in heart failure: literature review
Alieva A.M., Teplova N.V., Batov M.A., Voronkova K.V., Valiev R.K., Shnakhova L.M., Pinchuk T.V., Rakhaev A.M., Kalova M.R., Nikitin I.G.
Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region)
Airapetian A.A., Lazareva N.V., Reitblat O.M., Mezhonov E.M., Evgeny E.V., Prints Y.S., Zhirov I.V., Tereshchenko S.N., Boytsov S.A.
Endocan is a key player in cardiovascular disease: A review
Alieva A.M., Reznik E.V., Baykova I.E., Teplova N.V., Makeeva L.M., Voronkova K.V., Khadzhieva N.K., Modestova A.V., Totolyan G.G., Valiev R.K., Li A.M., Kotikova I.A., Nikitin I.G.
Anatomy of the coronary arteries and localization of coronary atherosclerosis in siblings with coronary heart disease
Kamolov I.H., Semitko S.P., Zhuravlev A.S., Chernysheva I.E., Tsereteli N.V., Sandodze T.S., Azarov A.V., Fomin V.V., Ioseliani D.G.
Exogenous ketone therapy for heart failure: A review
Aksenova Y.O., Osmolovskaya Y.F., Zhirov I.V., Beniashvili A.G., Morozova M.A., Tereshchenko S.N.
Differential diagnosis of amiodarone-induced thyrotoxicosis in a patient with atrial fibrillation and agranulocytosis on the background of thyrostatic therapy. Case report
Zherebchikova K.Y., Bubnov D.S., Ermolaeva A.S., Soltakhanova M.O., Sych Y.P., Ezhov M.V., Fadeev V.V.
The effect of active diuretic therapy on the sodium balance in patients with acute decompensation of chronic heart failure
Davydov V.V., Arehina E.L.
Acute decompensated heart failure. What has changed in the clinical guidelines in 2021?
Zhirov I.V., Nasonova S.N., Khalilova U.A., Osmolovskaya Y.F., Zhirova I.A., Gimadiev R.R., Chaikovskaia O.I., Reitblat O.M., Prints I.S., Kochetov A.G., Tereshchenko S.N.
Difference of genetic polymorphisms in patients with type 2 diabetes mellitus with absence or presence of chronic heart failure with preserved ejection fraction
Sveklina T.S., Shustov S.B., Kolyubaeva S.N., Kuchmin A.N., Kozlov V.A., Halimov Y.S., Konyaev V.V.
A clinical case of hereditary transthyretin amyloidosis. Case report
Shoshina A.A., Nasonova S.N., Zhirov I.V., Saidova M.A., Ansheles A.A., Meshkov A.N., Tereshchenko S.N.
Safety of dapagliflozin initiation in acute decompensated heart failure patients with reduced left ventricular ejection fraction
Poskakalova A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Therapy correction of concerned chronic heart failure and chronic obstructive pulmonary disease in a patient with first identified pulmonary tuberculosis. Case report
Bagisheva N.V., Mordyk A.V., Trukhan D.I., Viktorova I.A., Moiseeva M.V.
Acute heart failure: classification, diagnosis, general approaches to treatment
Zhirov I.V., Nasonova S.N., Khalilova U.A., Osmolovskaya Y.F., Chaikovskaia O.I., Zhirova I.A., Gimadiev R.R., Kochetov A.G., Tereshchenko S.N.
Molecular mechanisms of inflammation in the development of heart failure: A review
Buziashvili Y.I., Asymbekova E.U., Tugeeva E.F., Rakhimov A.Z., Shakhnazaryan L.S., Akildzhonov F.R.
Tumor necrosis factor gene polymorphism rs1800629 in patients with atherosclerotic cardiovascular diseases: A review
Khazova E.V., Bulashova O.V., Valeeva E.V.
Study of the rs1800795 polymorphism of the IL6 gene to verify the clinical portrait of a patient with chronic heart failure: gender aspects
Khazovа E.V., Boulashova O.V., Valeeva E.V.
Rational drug therapy of chronic heart failure: the role of mineralocorticoid receptor antagonists: review
Safronova N.V., Zhirov I.V., Tereshchenko S.N.
The role of interleukin-27 in atherosclerotic cardiovascular diseases: A review
Alieva A.M., Teplova N.V., Reznik E.V., Sarakaeva L.R., Rahaev A.M., Elmurzaeva D.A., Akkiev M.I., Shavaeva M.Y., Akkieva M.A., Nikitin I.G.
Heart failure as a complication of myocardial infarction: rational therapy. Case report
Zhirov I.V., Safronova N.V., Tereshchenko S.N.
Chronic heart failure – modification of treatment paradigm
Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Hyperuricemia and acute decompensation of heart failure: is there a causative link? A review
Sarieva L.H., Nasonova S.N., Zhirov I.V., Zhirova I.A., Tereshchenko S.N.
Catestanin – a promising biological marker for heart failure: A review
Alieva A.M., Teplova N.V., Reznik E.V., Ettinger O.A., Faradzhov R.A., Khachirova E.A., Kovtiukh I.V., Kotikova I.A., Sysoeva D.A., Bigushev I.R., Nikitin I.G.
Microporous surface as a new solution for stent surface modification: A review
Kamolov I.H., Asadov D.A., Sandodze T.S., Chernysheva I.E.
Possibilities of noninvasive diagnostics of cardiovascular diseases associated with atherosclerosis
Salyamova L.I., Pavlenko K.I., Khromova A.A., Oleynikov V.E.
Neopterin is a biomarker of chronic heart failure (review of modern literature)
Alieva A.M., Pinchuk T.V., Voronkova K.V., Shnakhova L.M., Ettinger O.A., Akhmedova M.F., Valiev R.K., Kalova M.R., Gasanova E.T., Nikitin I.G.
Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review
Alieva A.M., Teplova N.V., Reznik E.V., Baykova I.E., Khadzhieva N.K., Voronkova K.V., Kovtiukh I.V., Valiev R.K., Kotikova I.A., Nikitin I.G.
Non-alcoholic fatty liver disease and cardiovascular risks: A review
Kotovskaya Y.V.
POSSIBILITIES OF PHARMACEUTICAL TREATMENT OF CARDIOGENIC ENCEPHALOPATHY WITH THE USE OF RUSSIAN MEDICATION WITH METABOLIC ACTION LEVOCARNITINE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CONGESTIVE HEART FAILURE
Mozheiko M.E., Bushueva E.V., Potanina M.V., Ryabikhin E.A.
Fatal cardio-vascular events risk stratification in ischemic heart disease patients with implantable cardioverter-defibrillators: role of noninvasive electrophysiological predictors
Melnik N.V., Tsaregorodtsev D.A., Ilych I.L., Khamnagadaev I.A., Sulimov V.A.
WHICH ASPECTS ARE THE MOST SIGNIFICANT IN RUSSIAN AND EUROPEAN GUIDELINES? INTERVIEW
Trimetazidine (review of the latest foreign publications)
Akatova E.V.
The current status of transcatheter heart valve replacement, using the valve-in-valve technique
Imaev T.E., Komlev A.E., Kolegaev A.S., Lepilin P.M., Akchurin R.S.
Efficacy and safety of long-term use of prolonged bronchodilators in patients with cardiopulmonary pathology and chronic heart failure
Evdokimov V.V., Yushchuk E.N., Evdokimova A.G., Stryuk R.I.
Captopril effectiveness in treatment of patients with congestive heart failure and cardiopulmonary pathology
Evdokimov V.V., Evdokimova A.G., Kovalenko E.V., Tereshchenko O.I.
Inhibitor If-sinus channels ivabradine - a drug, increases the effectiveness of treatment of chronic heart failure and coronary heart disease
Trukhan D.I.
Asthma and cardiovascular disease
Ostroumova O.D., Goloborodova I.V., Voevodina N.Y., Fomina V.M., Seregin A.A.
Effectiveness and safety of bronchodilator use in chronic cardiac insufficiency of ischemic genesis comorbid with chronic obstructive pulmonary disease
Evdokimov V.V., Evdokimova A.G., Kovalenko E.V., Voronina G.V.
Ischemic heart disease and heart rate monitoring
Kirichenko A.A.
Chronic heart failure in the practice of the therapist: is it difficult to recognize it?
Kirichenko A.A., Ebseeva E.Y.
Tactics of management of patients with cardiovascular diseases. Roundtable report
Konradi A.O., Baranova E.I., Gurevich V.S., Zvartau N.E., Konstantinov V.O., Nifontov E.M., Obrezan A.G., Panov A.V., Sitnikova M.Y.
Heart failure and contrast-induced acute kidney injury in patients with coronary artery disease
Mironova O.I., Sivakova O.A., Deev A.D., Fomin V.V.
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: A CHOICE OF THE DRUG IN CLINICAL PRACTICE GIVEN THE EFFECTIVENESS AND SAFETY OF USE
Mubarakshina O.A., Liubavskaia S.S., Somova M.N., Batishcheva G.A.
Amyloid heart disease: pathomorphology, diagnostic approaches and treatment options
Rameeva A.S., Rameev V.V., Moiseev S.V., Tao P.P., Kozlovskaya L.V.
Treatment of chronic heart failure and arterial hypertension: two aims and one drug - fosinopril
Trukhan D.I.
The role of antagonists of mineralocorticoid receptors in the pharmacotherapy of chronic heart failure
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Dronova Y.M.
Modern possibilities of torasemide application in clinical practice
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Evstigneeva A.S.
Angiotensin II receptor antagonist - candesartan in the arsenal of therapist
Kirichenko A.A.
Glycemic control as a part of coronary stenosis prevention strategy in type 2 diabetes patients before and after transcutaneous coronary intervention
Salukhov V.V., Kadin S.V., Agliullin A.F.
Key features of candesartan application in clinical practice
Evdokimova A.G., Lozhkina M.V., Kovalenko E.V.
Vaccine prophylaxis in patients with chronic obstructive pulmonary disease: results of a two-year observation
Ignatova G.L., Antonov V.N., Rodionova O.V.
The relevance of prescribing triple neurohormonal blockade in real clinical practice: the role of mineralocorticoid receptor antagonists
Zhirov I.V.
P2-ADRENERGIC RECEPTORS GENETIC POLYMORPHISM, CARDIOVASCULAR DISORDERS AND INFLUENCE OF P-BLOCKERS’ EFFECTIVENESS
Leonova M.V.
MILDRONATE USE IN COMPLEX TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ITS INFLUENCE ON HEART AND VESSELS MORPHOFUNCTIONAL STATE
Mikhin V.P., Khlebodarov F.E., Vasil'eva D.A., Gromnatskii N.I.
Percutaneous coronary interventions in comparison with medical therapy in patients with chronic ischemic heart disease: results of long-term follow-up
Kuznetsov V.A., Samoilova E.P., Bessonov I.S., Gultyaeva E.P., Berdinskikh S.G., Gorbatenko E.A., Dyachkov S.M., Yaroslavskaya E.I.
Decreased cardiac mortality with nicorandil in patients with ischemic heart failure
Yoshihisa A., Sato Y., Watanabe S., Yokokawa T., Sato T., Suzuki S., Oikawa M., Kobayashi A., Takeishi Y.
The mineralocorticoid receptor blockers in the treatment of chronic heart failure
Kirichenko A.A.
Clinical aspects of application of candesartan
Rybachkova Y.V.
Liver damage in patients with ischemic chronic heart and type 2 diabetes - a treacherous tandem: possible additional organoprotective therapy
Statsenko M.E., Turkina S.V., Shilina N.N.
The characteristics of torasemide application in patients with arterial hypertension and chronic heart failure
Evdokimov V.V., Evdokimova A.G., Lozhkina M.V., Tebloev K.I.
Aggravation of coronary heart disease: the balance of risk and the risk of disease treatment
Braznik V.A., Zateyshchikov D.A.
Age aspects of acute myocardial infarction
Khorolets E.V., Shlyk S.V., Bychkova O.I.
Cardiology 2020. The patient with chronic heart failure: a new trajectory of life
Insulin resistance: focus on the pathogenesis of cardiomyopathy
Shishkova V.N., Martynov A.I.
COMPARATIVE PHARMACOEPIDEMIOLOGICAL CHARACTERISTICS OF THE PRESCRIPTIONS OF MEDICINES APPLIED AT PATIENTS WITH CHRONIC HEART FAILURE IN THE CONDITIONS OF TYPICAL PRACTICE OF KURSK AND CHISINAU
Povetkin S.V., Ghicavii V.I., Klyueva E.G., Batchinschi N.G., Pjdgurschi L.A., Turcan L.M.
Cognitive disorders in medical rehabilitation
Krasnov V.S., Shmonin A.A., Maltseva M.N., Melnikova E.V., Ivanova G.E.
Effect of nicorandil on the quality of life and course of the disease in patients with heart failure in ischemic heart disease
Makarovskaya V.V., Ryazanov A.S., Kudryavtsev A.A., Kapitonov K.I.
Modern instrumental diagnosis of coronary heart disease in women and its prognostic importance
Lupanov V.P.
Modern approaches to the use of torasemide in cardiovascular diseases
Baryshnikova G.A., Chorbinskaya S.A., Stepanova I.I.
Pathogenetic substantiation inclusion of taurine in the treatment of patients with diabetes mellitus type 2
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Gorbacheva E.E.
The arsenal of therapist: torasemide
Kirichenko A.A.
Chronic ischemic heart disease: treatment news
Karpov Y.A.
Efficacy and safety in clinical practice fosinopril
Stryuk R.I.
Reducing the risk of chronic heart failure development in patients with arterial hypertension from the position of evidence medicine (focus on candesartan)
Evdokimova A.G., Stryuk R.I., Evdokimov V.V., Golikova A.A.
Pharmacoeconomic analysis of the use of dapagliflozin in patients with NYHA class II-IV chronic heart failure with reduced left ventricular ejection fraction <40% in the Russian Federation
Nedogoda S.V., Tereshhenko S.N., Zhirov I.V., Salasyuk A.S., Villevalde S.V., Barykina I.N., Lutova V.O., Popova E.A.
OPTIMIZATION OF PHARMACOTHERAPY IN A POLYMORBID PATIENT WITH A COMBINATION OF CHRONIC HEART FAILURE AND CHRONIC KIDNEY DISEASE. CLINICAL CASE
Ostroumova O.D., Aliautdinova I.A., Butorov V.N., Kochetkov A.I.
Modern opportunities of nitropreparations in patients with ischemic heart disease: from angina to polymorbidity
Gorokhovskaya G.N., Vasyuk Y.A., Martynov A.I., Maychuk E.Y., Yun V.L., Truten I.V., Petina M.M.
Captopril in cardiovascular disease management
Terpigorev S.A., Nikishenkov A.M., Kabanova T.G., Zadionchenko V.S., Yalymov A.A., Shekhyan G.G., Shchikota A.M., Ivanova N.A., Bogatyrova K.M.
The evolution of mineralocorticoid receptor antagonists: spironolactone and eplerenone
Leonova M.V., Alimova E.E., Eremina Y.N.
Possibilities of perindopril and ivabradin in patients with hypertensive disease in the normalization of hemodynamics, myocardial dysfunction and vascular endothelium
Ivanova O.F., Lebedev P.A., Vvedenskaya I.P., Komarova M.V., Paranina E.V.
Stress-overcoming behaviour in patients with minor heart anomalies: is there an influence of sex?
Kodochigova A.I., Olenko E.S., Kirichuk V.F., Kurako M.M.
The use of proton pump inhibitors in patients with gastroesophageal reflux disease to ischemic heart disease
Komissarenko I.A., Levchenko S.V., Mikheeva O.M.
Violations of respiratory function in the combined chronic obstructive pulmonary disease and coronary heart disease
Ignatova G.L., Antonov V.N., Rodionova O.V.
Management of a patient with dyspnea on an outpatient admission
Vertkin A.L., Topolyansky A.V., Knorring G.Y., Shamuilova M.M.
Ventricular arrhythmias in chronic heart failure: features of treatment and the possibility of improving the prognosis
Bunin Y.A., Zolozova E.A.
Use of combination pills with acetylsalicylic acid and clopidogrel in coronary artery disease. Efficacy and assessment of adherence to treatment: Kobra Study
Lomakin N.V., Buryachkovskaya L.I., Senichkina A.A., Sumarokov A.B., Docenko U.V., Kazey V.I.
Fractalkin and cardiovascular disease
Alieva A.M., Almazova I.I., Pinchuk T.V., Reznik E.V., Rakhaev A.M., Nikitin I.G.
TORASEMIDE - THE DRUG FOR THE TREATMENT OF HEART FAILURE AND ARTERIAL HYPERTENSION
Trukhan D.I., Davydov E.L.
Systemic inflammatory markers as predictors of cardiac complications in patients with comorbid course of chronic obstructive pulmonary disease and ischemic heart disease
Ignatova G.L., Antonov V.N.
The place of antagonists of mineralocorticoid receptors in the treatment of chronic heart failure
Orlova N.V., Spiryakina Y.G.
Electrocardiographic predictors of sudden cardiac death
Nikiforov V.S., Metso K.V.
Principles of drug therapy of arterial hypertension
Zadionchenko V.S., Shekhyan G.G., Yalymov A.A., Shchikota A.M.
Heart damage in arterial hypertension. Management of hypertension and contractile dysfunction
Gurevich M.A., Kuzmenko N.A.
Beyond the scope of invasive cardiology
Vertkin A.L., Knorring G.Y.
Efficiency of coronary heart disease standard therapy in combination with nikorandil in patients with angina. Study of the correlation of endothelial dysfunction with data of laboratory and instrumental investigations
Solodova Y.A., Adamchik A.S.
Mineralocorticoid receptor antagonists: a dubious past and advanced future
Napalkov D.A.
Captopril in cardiological patients treatment: is there still place for the “first of the Mohicans”?
Valikulova F.Y., Koroleva L.Y., Melnichenko O.V., Duryndina E.M., Muradova F.N., Alekseeva M.M.
Sodium-glucose co-transporter-2 inhibitors in patients with heart failure. What's new? What are the prospects?
Erlikh A.D., Riabova D.V.
Difficulties in diagnosis and variants of the clinical course of hypertrophic cardiomyopathy in elderly patients
Krylova N.S., Maslova M.Y., Poteshkina N.G., Kovalevskaya E.A., Selivanova G.B.
SECONDARY PREVENTION IN STABLE ANGINA
Kirichenko A.A.
1 - 100 of 130 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies